Journal of Infection
Volume 61, Issue 2 , Pages 125-132, August 2010

Six weeks of antibiotic treatment is sufficient following surgery for septic arthroplasty

  • Louis Bernard

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
    • Division of Infectious Diseases, Bretionneau Hospital, University Hospitals of Tours, France
  • ,
  • Laurence Legout

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
  • ,
  • Line Zürcher-Pfund

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
  • ,
  • Richard Stern

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
  • ,
  • Peter Rohner

      Affiliations

    • Laboratory of Bacteriology, Geneva University Hospitals & Medical School, Geneva, Switzerland
  • ,
  • Robin Peter

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
  • ,
  • Mathieu Assal

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
  • ,
  • Daniel Lew

      Affiliations

    • Service of Infectious Diseases, Geneva University Hospitals & Medical School, Geneva, Switzerland
  • ,
  • Pierre Hoffmeyer

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
  • ,
  • Ilker Uçkay

      Affiliations

    • Orthopaedic Surgery Service, Geneva University Hospitals & Medical School, Geneva, Switzerland
    • Service of Infectious Diseases, Geneva University Hospitals & Medical School, Geneva, Switzerland
    • Corresponding Author InformationCorresponding author. Orthopaedic Surgery Service, Service of Infectious Diseases, Geneva University Hospitals, 4, Rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland. Tel.: +41 22 372 3311; fax: +41 22 372 3987.

Accepted 29 May 2010. published online 02 July 2010.

Summary 

Objectives

In the treatment of prosthetic joint infections (PJI), the benefit of antibiotic therapy for more than 6 weeks after surgery is uncertain. We compared PJI cure rates according to the duration of antibiotics, 6 versus 12 weeks.

Methods

A prospective observational non-randomized study in Geneva University Hospitals 1996–2007.

Results

A total of 144 PJI (62 hip arthroplasties, 62 knee arthroplasties, and 20 hip hemiarthroplasties) were included with a prolonged follow-up ranging from 26 to 65 months. Surgical treatment included 60 débridements with implant retention, 10 one-stage exchanges of the prosthesis, 57 two-stage exchanges, and 17 Girdlestone procedures or knee arthrodeses. Seventy episodes (49%) received 6 weeks antibiotic therapy and 74 episodes, 12 weeks. Cure was achieved in 115 episodes (80%). Cure rate did not change according to the duration of intravenous antibiotics (>8 days, 8–21 days, >21 days) (Kruskal–Wallis-test; p = 0.37). In multivariate analysis, none of the following parameters was statistically significantly associated with cure: two-stage exchange (odds ratio 1.1,95%CI 0.2–4.8); number of débridements (0.9, 0.4–1.9); six weeks antibiotherapy (2.7, 0.96–8.3); duration of intravenous course (1.0, 0.96–1.03); sinus tract (0.6, 0.2–1.7); or MRSA infection (0.5, 0.2–1.5), although implant retention showed a tendency for less cure (0.3, 0.1–1.1).

Conclusions

Following surgery for treatment of PJI, antibiotic therapy appears able to be limited to a 6-week course, with one week of intravenous administration. This approach needs confirmation in randomized trials.

Keywords: Oral antibiotic, Duration, Prosthetic joint, Infection, Surgery

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 There are no grants, financial support, financial interests, consultancy, commercial or other associations that could lead to a conflict of interest. All authors state that they have read and approved the manuscript. It has not been published elsewhere nor is it under consideration for publication by another journal. Different parts of the manuscript have been presented orally at the 6th and 10th French National Days of Infectiology, in Nice 2005 and Lyon 2009, respectively, and the Swiss Orthopaedic Congress in Geneva, June 2009.

PII: S0163-4453(10)00153-2

doi:10.1016/j.jinf.2010.05.005

Journal of Infection
Volume 61, Issue 2 , Pages 125-132, August 2010